INcrease Of VAgal TonE in CHF

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 730 participants.

Also called NCT01303718

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 730 participants (enrolled count) (from the registry)
Sponsor
BioControl Medical (from the registry)
Registry
  • NCT NCT01303718
Other papers using this trial's data
  • Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial Journal of the American College of Cardiology, 2016-07-12 DOI, PubMed 27058909

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Belgium, Germany, Israel, Netherlands, Poland, Serbia, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01303718. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
INcrease Of VAgal TonE in CHF
Acronym
INOVATE-HF
Condition
Left Ventricular Dysfunction
Condition
Heart Failure
Intervention (Device)
CardioFit® System
Intervention (Other)
Standard of Care
Lead sponsor
BioControl Medical (class: industry)

Record details

Record id
cardio:ct-nct01303718
Content hash
055b13ccc594645004f525b46dd2946075888be1d4ef2557661abfa3ca154798